Company / Operating Cash Flow
UTAH MEDICAL PRODUCTS INC Operating Cash Flow History
FY2016-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Operating Cash Flow
$22.3M
FY2025
5-year range
$17.1M / $22.3M
FY2021-FY2025
Trend
+5.4%
vs FY2024
Sector context
Sector data unavailable
Latest sector comparison
What the data says
Operating Cash Flow has fluctuated over the past 10 years, ranging from $14M in FY2017 to $22M in FY2025.
Based on SEC 10-K filings.
$22M in FY2025 with a 5-year CAGR of +5.8%.
Improved from $21M to $22M over the past 2 years.
Operating Cash Flow over time
Growth rates
- 3-Year CAGR
- +3.4%
- 5-Year CAGR
- +5.8%
- 10-Year CAGR
- -
Key checks
Key Insights
- 5-year CAGR of +5.8%, indicating consistent growth.
- In FY2025, operating cash flow increased 5.4% year-over-year.
- Lowest operating cash flow in the period was in FY2017.
Company context
Key Data Points
- Altman Z-Score 16.69 (safe zone, above 2.9 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Operating Cash FlowValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $22.3M | +5.4% |
| FY2024 | $21.1M | -0.3% |
| FY2023 | $21.2M | +5.3% |
| FY2022 | $20.1M | +18.1% |
| FY2021 | $17.1M | +1.3% |
| FY2020 | $16.8M | -0.4% |
| FY2019 | $16.9M | +16.4% |
| FY2018 | $14.5M | +5.3% |
| FY2017 | $13.8M | -10.3% |
| FY2016 | $15.4M | +25.0% |
As of FY2025 · SEC 10-K · Updated Jun 28, 2026